The future challenges facing the development of new antimicrobial drugs
Top Cited Papers
- 1 November 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 1 (11) , 895-910
- https://doi.org/10.1038/nrd940
Abstract
The emergence of resistance to antibacterial agents is a pressing concern for human health. New drugs to combat this problem are therefore in great demand, but as past experience indicates, the time for resistance to new drugs to develop is often short. Conventionally, antibacterial drugs have been developed on the basis of their ability to inhibit bacterial multiplication, and this remains at the core of most approaches to discover new antibacterial drugs. Here, we focus primarily on an alternative novel strategy for antibacterial drug development that could potentially alleviate the current situation of drug resistance--targeting non-multiplying latent bacteria, which prolong the duration of antimicrobial chemotherapy and so might increase the rate of development of resistance.Keywords
This publication has 123 references indexed in Scilit:
- Increased levels ofsigJmRNA in late stationary phase cultures ofMycobacterium tuberculosisdetected by DNA array hybridisationFEMS Microbiology Letters, 2001
- Will genomics revolutionize antimicrobial drug discovery?Current Opinion in Microbiology, 2000
- Don't keep taking the tablets?The Lancet, 1999
- The prevalence of antibiotic-resistant faecalEscherichia coli in healthy volunteers in VenezuelaInfection, 1998
- β-Lactam resistance in normal faecal flora from South AfricaEpidemiology and Infection, 1995
- Starvation‐induced expression of SspA and SspB: the effects of a null mutation in sspA on Escherichia coli protein synthesis and survival during growth and prolonged starvationMolecular Microbiology, 1994
- Factors affecting the selection and use of tetrazolium salts as cytochemical indicators of microbial viability and activityJournal of Applied Bacteriology, 1993
- Antibiotic resistance ofEscherichia coli in fecal samples of healthy people in two different areas in an industrialized countryInfection, 1992
- Screening of natural products for antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- R-factor Mediated Dihydrofolate Reductases which Confer Trimethoprim ResistanceJournal of General Microbiology, 1978